Home/ Supplements/ Berberine/ ALAmax Protect

ALAmax Protect

product on market Capsule XYMOGEN Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Berberine HCl and alpha-lipoic acid are researched for their roles in supporting glucose metabolism and antioxidant activity. There is strong evidence for their efficacy in managing metabolic markers, although overall evidence coverage for this specific formulation is limited. The profile maintains a high safety rating.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for ALAmax Protect
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Capsule(s)
Serving Size
60
Servings
Other Combinations
Product Type
50%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

500 mg
Market median: 500.0mg (234 products) 95 studies (A:0, B:35)
Market median: 200.0mg (198 products) 6 studies — no high-quality reviews

Other Ingredients

HPMC Ascorbyl Palmitate L-Leucine Silica Medium-Chain Triglyceride Oil
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

DIRECTIONS: Take two capsules twice daily, or as directed by your healthcare professional.

Warnings & Precautions

CAUTIONS: Consult your healthcare practitioner prior to use.

Do not use if tamper seal is damaged.

Keep out of reach of children.

STORAGE: Keep tightly closed in a cool, dry place out of reach of children.

Individuals taking medications, especially medications that are metabolized by cytochrome P450 enzymes or that affect blood glucose, should discuss potential interactions with their healthcare practitioner. Do not use if you are pregnant, nursing, or trying to conceive.

Formulation Notes

It deliver both alpha-lipoic acid (ALA) and the plant alkaloid berberine in one convenient formula.

DOES NOT CONTAIN: Wheat, gluten, corn, yeast, soy, dairy products, fish, shellfish, peanuts, tree nuts, egg, ingredients derived from genetically modified organisms (GMOs), artificial sweeteners, or preservatives.

Berberine and ALA Complex

Additional Information

These ingredients have been observed to support insulin activity and glucose metabolism. More recent research also suggests a role for berberine in supporting normal AC levels.

STORAGE: Keep tightly closed in a cool, dry place out of reach of children.

Pharmaceutical Grade Professional Use Only

VEGETABLE CAPSULES

ZLB-ALAPRO-01 REV. 063014

This package is completely recyclable {recyclable}

EXCLUSIVE PROFESSIONAL FORMULAS

Metadata

Product Details

UPC / SKU8 71149 00466 8
DSLD Entry Date2014-10-10
Product TypeOther Combinations
FormCapsule
BrandXYMOGEN
DSLD ID37373
Data Updated2026-04-11
Research

Research Evidence

98
Research Sources
55
Avg Quality
48
Systematic Review
39
Meta Analysis
4
Rct
4
Clinical Trial
1
Other
1
Narrative Review
1
Openfda Safety
B Efficacy and safety of berberine for dyslipidaemias: A systematic review and meta-analysis of randomized clinical trials
Meta Analysis Phytomedicine : international journal of phytotherapy and phytopharmacology 2018 PubMed DOI
B Effects berberine-silymarin on liver enzymes: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Clinical nutrition ESPEN 2022 PubMed DOI
B Efficacy and safety of berberine for several cardiovascular diseases: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Phytomedicine : international journal of phytotherapy and phytopharmacology 2023 PubMed DOI
B Effect of Berberine on C-reactive protein: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Complementary therapies in medicine 2019 PubMed DOI
B Overall and Sex-Specific Effect of Berberine on Glycemic and Insulin-Related Traits: a Systematic Review and Meta-Analysis of Randomized Controlled Trials
Meta Analysis The Journal of nutrition 2023 PubMed DOI
B The clinical efficacy and safety of berberine in the treatment of non-alcoholic fatty liver disease: a meta-analysis and systematic review
Meta Analysis Journal of translational medicine 2024 PubMed DOI
B Berberine Effects in Pre-Fibrotic Stages of Non-Alcoholic Fatty Liver Disease-Clinical and Pre-Clinical Overview and Systematic Review of the Literature
Systematic Review International journal of molecular sciences 2024 PubMed DOI
B Efficacy and Safety of Berberine Alone or Combined with Statins for the Treatment of Hyperlipidemia: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials
Meta Analysis The American journal of Chinese medicine 2019 PubMed DOI
B Effects of Berries, Phytochemicals, and Probiotics on Atherosclerosis through Gut Microbiota Modification: A Meta-Analysis of Animal Studies
Meta Analysis International journal of molecular sciences 2023 PubMed DOI
B Berberine Ursodeoxycholate for the Treatment of Type 2 Diabetes: A Randomized Clinical Trial
Rct JAMA network open 2025 PubMed DOI
View all evidence for Berberine →
Compare

Similar Products

View all Berberine products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.